Fenna de Vries

3PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 13, 2026
Deprescribing opportunities for patients with advanced non-small cell lung cancer: an observational study of potentially inappropriate medications and stakeholders' perspectives.

|Jul 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Fenna de Vries, Eric J F Franssen, Arthur A J Smit

|Jul 24, 2025
Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancer.

Fenna de Vries, Leila-Sophie Otten, Berber Piet

Pageof 1

Frequent Collaborators

2 joint publications

Eric J F Franssen

2 joint publications

Michel van den Heuvel

2 joint publications

Rob Ter Heine

1 joint publications

Leila-Sophie Otten